Tivozanib 11014-0471-02
- Manufacturer
- Catalent Pharma Solution, Llc
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- August 24, 2017
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tivozanib Hydrochloride | 1.35 mg/1 |
Selected Package
11014-0471-02Selected1 BAG in 1 DRUM (11014-0471-2) / 93750 CAPSULE in 1 BAG